{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:19:16Z","timestamp":1773746356812,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ejvesreports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EJVES Vascular Forum"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ejvsvf.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T12:12:20Z","timestamp":1645013540000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-3176","authenticated-orcid":false,"given":"Eberhard","family":"Grambow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Junghans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Christian","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil Christian","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd Joachim","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justus","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvsvf.2022.02.004_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejvs.2019.10.016","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections","volume":"59","author":"Chakf\u00e9","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jvs.2016.07.126","article-title":"A\u00a0multicenter experience with infected abdominal aortic endograft explantation","volume":"65","author":"Chaufour","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0002-9610(99)00146-4","article-title":"The results of in situ prosthetic replacement for infected aortic grafts","volume":"178","author":"Young","year":"1999","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1469-0691.12651","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"20","author":"Maci\u00e0","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejvs.2011.12.029","article-title":"Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in\u00a0vitro comparison between daptomycin, rifampin and nebacetin","volume":"43","author":"Bisdas","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/med.21593","article-title":"Phage therapy: current status and perspectives","volume":"40","author":"G\u00f3rski","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.12659\/MSMBR.902879","article-title":"Vascular graft impregnation with antibiotics: the influence of high concentrations of rifampin, vancomycin, daptomycin, and bacteriophage endolysin HY-133 on viability of vascular cells","volume":"23","author":"Herten","year":"2017","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/antibiotics9050232","article-title":"Bacteriophage therapy for critical infections related to cardiothoracic surgery","volume":"9","author":"Rubalskii","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejvsvf.2022.02.004_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol Med Public Health"}],"container-title":["EJVES Vascular Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666688X22000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666688X22000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:05:52Z","timestamp":1763006752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666688X22000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":10,"alternative-id":["S2666688X22000193"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvsvf.2022.02.004","relation":{},"ISSN":["2666-688X"],"issn-type":[{"value":"2666-688X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application","name":"articletitle","label":"Article Title"},{"value":"EJVES Vascular Forum","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvsvf.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}